Table of Contents
This week brings good news for Finnish game developer Remedy Entertainment. On October 15, 2026, the company announced that its new game, Control Resonant, had surpassed 1 million copies sold. This mark makes it the fastest-selling game in Remedy’s 31-year history, surpassing even Alan Wake 2.
(Image credit: Remedy Entertainment)
The numbers are not large, but the implications are huge.
To be honest, selling 1 million copies in 3 weeks isn’t exactly a record-breaking pace in today’s gaming industry. PC Gamer reports that The Blood of Dawnwalker reached this mark in just 3 days, Wardogs in 1 day, and Subnautica 2 sold twice as many copies in just 12 hours.
But Remedy’s story is different. The studio is known for its unique, memorable, and critically acclaimed games, but it hasn’t had a major “home run” in terms of sales to date. So this achievement is truly special for them.
Read More: Jetpacks arrive in GTA 5: San Andreas magic now in the skies of Los Santos
Comparison to Alan Wake 2
Alan Wake 2, released in 2023, has already won numerous awards for its story and art direction. It could have won even more if it weren’t for the legendary Baldur’s Gate 3. That game took two months to sell 1 million copies. At the time, it was Remedy’s fastest-selling game, far surpassing its predecessor, Control. Now, Control Resonant has achieved the same feat in just three weeks.
Read More: Forza Horizon 6: Where to find this week’s Takashiro Treasure Hunt? Complete location guide
The real challenge: profits
Remedy’s biggest problem has been revenues exceeding sales. It took Alan Wake 2 over a year and nearly two million copies sold to turn a profit. This means the game received widespread praise, but it took a long time for the company to start filling its pockets.
That’s why the company appointed a new CEO, Jean-Charles Gaudechon, in February. Chairman Henri Österlund said at the time that the appointment was made to lead Remedy into a period of “profitable growth.” Gaudechon now describes Control Resonant’s sales as “off to a very strong start.”
Read More: Caves of Qud Diaspora: Play as a Sapient Tree in December
What did the CEO say?
According to Gaudechon, Control Resonant is Remedy’s first major release that the company has self-published. The game comes at a time when the market is facing stiff competition from the industry’s biggest names. He said the game clearly reflects Remedy’s identity: bold ideas and a distinctive style.
He thanked the players and his team. He also said that the company always believed that Control deserved a wider audience, and this launch showed that it was possible. He said that the game is not only connecting with old fans but also bringing a large number of new players to the Control world, strengthening its long-term prospects.
Two franchises, and more to come
Gaudechon also hinted that Remedy now has two established franchises, Control and Alan Wake. The company’s focus will be on strengthening, supporting, and expanding these. He added that “there’s still a lot to come” from these worlds. This means it’s safe to expect DLC, updates, or new projects in the future.
What do the reviews say?
PC Gamer’s review called Control Resonant a beautiful sequel, but also noted that its focus on melee action was mediocre. A launch day hotfix addressed the reviewer’s main complaint, suggesting the developers are responding quickly to feedback.
Read More: Humankind 2: After Civ 7’s faltering, can Amplitude carry the torch for 4X games?
What to look forward to?
The true picture will emerge on November 3rd, when Remedy releases its Q3 business review. This will reveal how much the Control Resonant sales have impacted the company’s earnings. If the numbers are positive, this could be a major turning point for Remedy.
This news shows that not every success means breaking records. Sometimes, the biggest victory for a company is simply breaking its own record and moving in the right direction. For Remedy, Control Resonant is just that.
Have you played Control Resonant or are you planning to? Let us know in the comments.
